Skip to main content
. 2015 Jun 26;10(6):e0130345. doi: 10.1371/journal.pone.0130345

Table 1. Characteristics of patients with or without visible PALNs a .

Characteristics (N = 3388) Patients without visible PALNs Patients with visible PALNs P value
N = 2979 (%) N = 409 (%)
Age (years) < 65 1075 (36.1) 171 (41.8) 0.014
≥ 65 1904 (63.9) 238 (58.2)
Gender Male 1878 (63.0) 281 (68.7) 0.014
Female 1101 (37.0) 128 (31.3)
Tumor Location Colon 2192 (73.6) 301 (73.6) 0.525
Rectum 787 (26.4) 108 (26.4)
Histological type Adenocarcinoma 2817 (94.6) 286 (94.4) 0.704
Mucinous adenocarcinoma 115 (3.9) 14 (3.4)
Signet ring cell adenocarcinoma 40 (1.3) 7 (1.7)
Carcinoma, NOS 7 (0.2) 2 (0.5)
Primary tumor Lymphovascular invasion Negative 2645 (88.8) 338 (82.6) <0.001
Positive 334 (11.2) 71 (17.4)
Perineural invasion Negative 2886 (96.9) 393 (96.1) 0.236
Positive 93 (3.1) 16 (3.9)
Grade b Lower 2734 (91.8) 369 (90.2) 0.166
High 245 (8.2) 40 (9.8)
Pathologic staging pT 1 435(14.6) 28(6.8) <0.001
2 462(15.5) 50(12.2)
3 1905(63.9) 288(70.4)
4 177(5.9) 43(10.5)
pN N0 1974 (66.3) 220 (53.8) <0.001
N+ 1005 (33.7) 189 (46.2)
Preoperative serum CEA level (ng/mL) <10 2424 (85.3) 322 (81.1) 0.021
≥10 419 (14.7) 75 (18.9)
Data available 2843 397
5-year overall survival 76% 67% 0.015

aAll patients were diagnosed as having no distant metastases

bLower grade represents well or moderately differentiated histology and high grade represents poorly differentiated histology or mucinous carcinoma.

PALNs, para-aortic lymph nodes; CRC, colorectal cancer; NOS, not otherwise specified; CEA, carcinoembryonic antigen